254 related articles for article (PubMed ID: 26980570)
21. Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation.
Jiang Q; Isquith J; Zipeto MA; Diep RH; Pham J; Delos Santos N; Reynoso E; Chau J; Leu H; Lazzari E; Melese E; Ma W; Fang R; Minden M; Morris S; Ren B; Pineda G; Holm F; Jamieson C
Cancer Cell; 2019 Jan; 35(1):81-94.e7. PubMed ID: 30612940
[TBL] [Abstract][Full Text] [Related]
22. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure.
Haas U; Sczakiel G; Laufer SD
RNA Biol; 2012 Jun; 9(6):924-37. PubMed ID: 22664914
[TBL] [Abstract][Full Text] [Related]
24. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
25. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
26. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
27. 3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk.
Park HJ; Ji P; Kim S; Xia Z; Rodriguez B; Li L; Su J; Chen K; Masamha CP; Baillat D; Fontes-Garfias CR; Shyu AB; Neilson JR; Wagner EJ; Li W
Nat Genet; 2018 Jun; 50(6):783-789. PubMed ID: 29785014
[TBL] [Abstract][Full Text] [Related]
28. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
[TBL] [Abstract][Full Text] [Related]
29. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
[TBL] [Abstract][Full Text] [Related]
30. ATM is down-regulated by N-Myc-regulated microRNA-421.
Hu H; Du L; Nagabayashi G; Seeger RC; Gatti RA
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1506-11. PubMed ID: 20080624
[TBL] [Abstract][Full Text] [Related]
31. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
32. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
Velazquez-Torres G; Shoshan E; Ivan C; Huang L; Fuentes-Mattei E; Paret H; Kim SJ; Rodriguez-Aguayo C; Xie V; Brooks D; Jones SJM; Robertson AG; Calin G; Lopez-Berenstein G; Sood A; Bar-Eli M
Nat Commun; 2018 Jan; 9(1):461. PubMed ID: 29386624
[TBL] [Abstract][Full Text] [Related]
33. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
35. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
[TBL] [Abstract][Full Text] [Related]
36. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
37. Adenosine deamination in human transcripts generates novel microRNA binding sites.
Borchert GM; Gilmore BL; Spengler RM; Xing Y; Lanier W; Bhattacharya D; Davidson BL
Hum Mol Genet; 2009 Dec; 18(24):4801-7. PubMed ID: 19776031
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells.
Fabbri E; Montagner G; Bianchi N; Finotti A; Borgatti M; Lampronti I; Cabrini G; Gambari R
Oncol Rep; 2016 May; 35(5):2866-72. PubMed ID: 26986724
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer.
Wu CW; Dong YJ; Liang QY; He XQ; Ng SS; Chan FK; Sung JJ; Yu J
PLoS One; 2013; 8(2):e57036. PubMed ID: 23437304
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome.
Peng Z; Cheng Y; Tan BC; Kang L; Tian Z; Zhu Y; Zhang W; Liang Y; Hu X; Tan X; Guo J; Dong Z; Liang Y; Bao L; Wang J
Nat Biotechnol; 2012 Feb; 30(3):253-60. PubMed ID: 22327324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
